Kanchana TK, director general of the Organisation of Pharmaceutical Producers of India (OPPI), the association which represents the interests of research-based pharmaceutical companies in India, discusses regulatory reform and how OPPI is helping to shape the Indian healthcare system.
Please introduce yourself to our international readers and your journey to becoming head of the OPPI.
"A drug policy that enhances access to healthcare, encourages innovation and enables ease of doing business can be the only sustainable way to address the unique healthcare challenges that India faces."
